CoChat

Direct activation of G-protein-gated inward rectifying K+ channels promotes nonrapid eye movement sleep

Open access
Zou, Bende, Cao, William S, Guan, Zhiwei, Xiao, Kui, Pascual, Conrado, Xie, Julian, Zhang, Jingxi, Xie, James, Kayser, Frank, Lindsley, Craig W, Weaver, C David, Fang, Jidong, Xie, Xinmin (Simon) · 2019 · Sleep
Cited by 15

The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.

Abstract

STUDY OBJECTIVES: A major challenge in treating insomnia is to find effective medicines with fewer side effects. Activation of G-protein-gated inward rectifying K+ channels (GIRKs) by GABAB agonists baclofen or γ-hydroxybutyric acid (GHB) promotes nonrapid eye movement (NREM) sleep and consolidates sleep. However, baclofen has poor brain penetration, GHB possesses abuse liability, and in rodents both drugs cause spike-wave discharges (SWDs), an absence seizure activity. We tested the hypothesis that direct GIRK activation promotes sleep without inducing SWD using ML297, a potent and selective GIRK activator. METHODS: Whole-cell patch-clamp recordings from hypocretin/orexin or hippocampal neurons in mouse brain slices were made to study neuronal excitability and synaptic activity; spontaneous activity, locomotion, contextual and tone-conditioned memory, and novel object recognition were assessed. Electroencephalogram/electromyogram (EEG/EMG) recordings were used to study GIRK modulation of sleep. RESULTS: ML297, like baclofen, caused membrane hyperpolarization, decreased input resistance, and blockade of spontaneous action potentials. Unlike baclofen, ML297 (5-10 µM) did not cause significant depression of postsynaptic excitatory and inhibitory currents (EPSCs-IPSCs), indicating preferential postsynaptic inhibition. ML297 (30 mg/kg, i.p.) inhibited wake activity and locomotion, and preferentially increased NREM sleep without altering EEG delta power, REM sleep, inducing SWDs, or impairing conditioned memory and novel object recognition. CONCLUSIONS: This study finds that direct activation of neuronal GIRK channels modulates postsynaptic membrane excitability and prolongs NREM sleep without changing sleep intensity, inducing SWDs, or impairing memory in rodents. These results suggest that direct GIRK activation with a selective compound may present an innovative approach for the treatment of chronic insomnia.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1093/sleep/zsy244

Cites

4 of 4 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 4 references

Research works printed but not linked: 52

  1. Kaczor, 2016, Prevalence and consequences of insomnia in pediatric population, Psychiatr Pol., 50, 555, 10.12740/PP/61226 · DOI
  2. Lane, 2017, Genome-wide association analyses of sleep disturbance traits identify new loci and highlight shared genetics with neuropsychiatric and metabolic traits, Nat Genet., 49, 274, 10.1038/ng.3749 · DOI · Paper page
  3. Angarita, 2016, Sleep abnormalities associated with alcohol, cannabis, cocaine, and opiate use: a comprehensive review, Addict Sci Clin Pract., 11, 9, 10.1186/s13722-016-0056-7 · DOI · Paper page
  4. McCleery, 2016, Pharmacotherapies for sleep disturbances in dementia, Cochrane Database Syst Rev., 11, CD009178
  5. Porter, 2015, Sleep, cognition and dementia, Curr Psychiatry Rep., 17, 97, 10.1007/s11920-015-0631-8 · DOI
  6. Rodrigues, 2016, Pharmacological interventions for daytime sleepiness and sleep disorders in Parkinson’s disease: systematic review and meta-analysis, Parkinsonism Relat Disord, 27, 25, 10.1016/j.parkreldis.2016.03.002 · DOI
  7. Gilbert, 2015, Sleep disturbances, TBI and PTSD: implications for treatment and recovery, Clin Psychol Rev., 40, 195, 10.1016/j.cpr.2015.05.008 · DOI · Paper page
  8. Osorio, 2011, Greater risk of Alzheimer’s disease in older adults with insomnia, J Am Geriatr Soc., 59, 559, 10.1111/j.1532-5415.2010.03288.x · DOI · Paper page
  9. Vandrey, 2014, Interactions between disordered sleep, post-traumatic stress disorder, and substance use disorders, Int Rev Psychiatry., 26, 237, 10.3109/09540261.2014.901300 · DOI · Paper page
  10. Coffey, 2016, Reversal of the sleep-wake cycle by heroin self-administration in rats, Brain Res Bull., 123, 33, 10.1016/j.brainresbull.2015.09.008 · DOI
  11. Brower, 2010, Prevalence and correlates of withdrawal-related insomnia among adults with alcohol dependence: results from a national survey, Am J Addict., 19, 238, 10.1111/j.1521-0391.2010.00035.x · DOI · Paper page
  12. Maulik, 2002, Coping behaviors and relapse precipitants in opioid dependence: a study from North India, J Subst Abuse Treat., 22, 135, 10.1016/S0740-5472(02)00225-8 · DOI
  13. Raj, 2000, Relapse precipitants in opiate addiction: assessment in community treatment setting, Indian J Psychiatry., 42, 253
  14. Brannan, 2005, Duloxetine 60 mg once-daily in the treatment of painful physical symptoms in patients with major depressive disorder, J Psychiatr Res., 39, 43, 10.1016/j.jpsychires.2004.04.011 · DOI · Paper page
  15. Brown, 2011, A review of sodium oxybate and baclofen in the treatment of sleep disorders, Curr Pharm Des., 17, 1430, 10.2174/138161211796197098 · DOI
  16. Richey, 2011, Pharmacological advances in the treatment of insomnia, Curr Pharm Des., 17, 1471, 10.2174/138161211796197052 · DOI · Paper page
  17. Scarff, 2015, Suvorexant for Adults with Insomnia, J S C Med Assoc., 111, 28
  18. Owen, 2016, Suvorexant: efficacy and safety profile of a dual orexin receptor antagonist in treating insomnia, Drugs Today (Barc)., 52, 29, 10.1358/dot.2016.52.1.2439940 · DOI
  19. Sutton, 2015, Profile of suvorexant in the management of insomnia, Drug Des Devel Ther., 9, 6035, 10.2147/DDDT.S73224 · DOI
  20. Szabadi, 2014, Selective targets for arousal-modifying drugs: implications for the treatment of sleep disorders, Drug Discov Today., 19, 701, 10.1016/j.drudis.2014.01.001 · DOI
  21. Monti, 2017, Zolpidem’s use for insomnia, Asian J Psychiatr., 25, 79, 10.1016/j.ajp.2016.10.006 · DOI
  22. Kaufmann, 2013, ML297 (VU0456810), the first potent and selective activator of the GIRK potassium channel, displays antiepileptic properties in mice, ACS Chem Neurosci., 4, 1278, 10.1021/cn400062a · DOI · Paper page
  23. Logothetis, 2015, Unifying mechanism of controlling kir3 channel activity by g proteins and phosphoinositides, Int Rev Neurobiol., 123, 1, 10.1016/bs.irn.2015.05.013 · DOI
  24. Logothetis, 1999, Gating of G protein-sensitive inwardly rectifying K+ channels through phosphatidylinositol 4,5-bisphosphate, J Physiol., 520 Pt 3, 630, 10.1111/j.1469-7793.1999.00630.x · DOI
  25. Xie, 1992, gamma-Hydroxybutyrate depresses monosynaptic excitatory and inhibitory postsynaptic potentials in rat hippocampal slices, Eur J Pharmacol., 223, 193, 10.1016/0014-2999(92)94839-N · DOI
  26. Black, 2009, The nightly administration of sodium oxybate results in significant reduction in the nocturnal sleep disruption of patients with narcolepsy, Sleep Med., 10, 829, 10.1016/j.sleep.2009.05.004 · DOI
  27. Black, 2016, Impact of sodium oxybate, modafinil, and combination treatment on excessive daytime sleepiness in patients who have narcolepsy with or without cataplexy, Sleep Med., 24, 57, 10.1016/j.sleep.2016.07.010 · DOI
  28. Black, 2014, GABAB agonism promotes sleep and reduces cataplexy in murine narcolepsy, J Neurosci., 34, 6485, 10.1523/JNEUROSCI.0080-14.2014 · DOI
  29. Roth, 2017, Effect of sodium oxybate on disrupted nighttime sleep in patients with narcolepsy, J Sleep Res., 26, 407, 10.1111/jsr.12468 · DOI
  30. Snead, 1992, Evidence for GABAB-mediated mechanisms in experimental generalized absence seizures, Eur J Pharmacol., 213, 343, 10.1016/0014-2999(92)90623-C · DOI · Paper page
  31. Stewart, 2009, Severity of atypical absence phenotype in GABAB transgenic mice is subunit specific, Epilepsy Behav., 14, 577, 10.1016/j.yebeh.2009.01.019 · DOI
  32. Ostojić, 2013, GABAB receptors as a common target for hypothermia and spike and wave seizures: intersecting mechanisms of thermoregulation and absence epilepsy, Neuroscience., 238, 39, 10.1016/j.neuroscience.2013.01.072 · DOI
  33. Muraki, 2004, Serotonergic regulation of the orexin/hypocretin neurons through the 5-HT1A receptor, J Neurosci., 24, 7159, 10.1523/JNEUROSCI.1027-04.2004 · DOI · Paper page
  34. Xie, 2008, Hypocretin/orexin and nociceptin/orphanin FQ coordinately regulate analgesia in a mouse model of stress-induced analgesia, J Clin Invest., 118, 2471
  35. Khroyan, 2012, Rodent motor and neuropsychological behaviour measured in home cages using the integrated modular platform SmartCage™, Clin Exp Pharmacol Physiol., 39, 614, 10.1111/j.1440-1681.2012.05719.x · DOI
  36. Dudhgaonkar, 2008, Synergistic interaction between meloxicam and aminoguanidine in formalin-induced nociception in mice, Eur J Pain., 12, 321, 10.1016/j.ejpain.2007.06.006 · DOI
  37. Kotecki, 2015, GIRK channels modulate opioid-induced motor activity in a cell type- and subunit-dependent manner, J Neurosci., 35, 7131, 10.1523/JNEUROSCI.5051-14.2015 · DOI · Paper page
  38. Radulovic, 1998, Generalization of fear responses in C57BL/6N mice subjected to one-trial foreground contextual fear conditioning, Behav Brain Res., 95, 179, 10.1016/S0166-4328(98)00039-4 · DOI
  39. Hicks, 2016, Voluntary wheel-running attenuates insulin and weight gain and affects anxiety-like behaviors in C57BL6/J mice exposed to a high-fat diet, Behav Brain Res., 310, 1, 10.1016/j.bbr.2016.04.051 · DOI
  40. Lueptow, 2017, Novel object recognition test for the investigation of learning and memory in mice, J Vis Exp, 10.3791/55718 · doi:10.3791/55718 · Paper page
  41. Xie, 2006, GABA(B) receptor-mediated modulation of hypocretin/orexin neurones in mouse hypothalamus, J Physiol., 574, 399, 10.1113/jphysiol.2006.108266 · DOI · Paper page
  42. Ladera, 2008, Pre-synaptic GABA receptors inhibit glutamate release through GIRK channels in rat cerebral cortex, J Neurochem., 107, 1506, 10.1111/j.1471-4159.2008.05712.x · DOI · Paper page
  43. Sarvey, 1989, Long-term potentiation: studies in the hippocampal slice, J Neurosci Methods., 28, 109, 10.1016/0165-0270(89)90016-2 · DOI
  44. Thompson, 1992, Comparison of the actions of adenosine at pre- and postsynaptic receptors in the rat hippocampus in vitro, J Physiol., 451, 347, 10.1113/jphysiol.1992.sp019168 · DOI · Paper page
  45. Qu, 2016, Automated monitoring of early neurobehavioral changes in mice following traumatic brain injury, Neural Regen Res., 11, 248, 10.4103/1673-5374.177732 · DOI
  46. Rajasekaran, 2014, Reduced locomotor activity correlates with increased severity of arthritis in a mouse model of antibody-induced arthritis, Open J Rheumat Autoimmune Dis, 4, 62, 10.4236/ojra.2014.41010 · DOI
  47. Shoji, 2014, Contextual and cued fear conditioning test using a video analyzing system in mice, J Vis Exp, 10.3791/50871 · DOI · Paper page
  48. Harashima, 2006, Abnormal expression of the G-protein-activated inwardly rectifying potassium channel 2 (GIRK2) in hippocampus, frontal cortex, and substantia nigra of Ts65Dn mouse: a model of Down syndrome, J Comp Neurol., 494, 815, 10.1002/cne.20844 · DOI · Paper page
  49. Marron Fernandez de Velasco, 2017, GIRK2 splice variants and neuronal G protein-gated K+ channels: implications for channel function and behavior, Scientific reports, 7, 1639, 10.1038/s41598-017-01820-2 · DOI
  50. Yi, 2001, Controlling potassium channel activities: interplay between the membrane and intracellular factors, Proc Natl Acad Sci USA, 98, 11016, 10.1073/pnas.191351798 · DOI
  51. Nagi, 2014, Kir3 channel signaling complexes: focus on opioid receptor signaling, Front Cell Neurosci., 8, 186, 10.3389/fncel.2014.00186 · DOI · Paper page
  52. Huang, 2018, GIRK1-mediated inwardly rectifying potassium current suppresses the epileptiform burst activities and the potential antiepileptic effect of ML297, Biomed Pharmacother., 101, 362, 10.1016/j.biopha.2018.02.114 · DOI

Cited by

See all 15

Metadata

Authors
Zou, B., Cao, W. S., Guan, Z., Xiao, K., Pascual, C., Xie, J., Zhang, J., Xie, J., Kayser, F., Lindsley, C. W., Weaver, C. D., Fang, J., & Xie, X. (.
Venue
Sleep
Published
2018-12-11
Volume
42
Issue
3
ISSN
  • 0161-8105 (ISSN-L)
  • 1550-9109
OpenAlex
W2905518523
Cited by
15
References
4
FWCI
0.69
Type
journal article
Language
en
Open access
green
Funders
National Institutes of Health (R43 HL142315, R42 HL084990, R44 AG043203, R44 NS086343)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Direct activation of G-protein-gated inward rectifying K+ channels promotes nonrapid eye movement sleep. https://app.cochat.ai/papers/10.1093/sleep/zsy244
The paper
Zou, B., Cao, W. S., Guan, Z., Xiao, K., Pascual, C., Xie, J., Zhang, J., Xie, J., Kayser, F., Lindsley, C. W., Weaver, C. D., Fang, J., & Xie, X. (. (2019). Direct activation of G-protein-gated inward rectifying K+ channels promotes nonrapid eye movement sleep. Sleep. https://doi.org/10.1093/sleep/zsy244

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.